Clearpoint Neuro share price today

(CLPT)

Clearpoint Neuro share price is $15.71 & ₹1,338.46 as on 25 Dec 2024, 2.30 'hrs' IST

$15.71

▲

1.07

(7.35%)

Market is closed - opens 8 PM, 26 Dec 2024

View live Clearpoint Neuro share price in Dollar and Rupees. Guide to invest in Clearpoint Neuro from India. Also see the sentimental analysis on Indian investors investing in Clearpoint Neuro. Get details on the Indian mutual funds that are investing in Clearpoint Neuro. Get Analyst recommendations and forecasts along with all the Clearpoint Neuro's financials.

Clearpoint Neuro share price movements

Today's Low: $14.71
Today's High: $15.75
$15.71
6.36%
Downside
Day's Volatility :6.6%
Upside
0.25%
52 Weeks Low: $5.11
52 Weeks High: $17.47
$15.71
67.5%
Downside
52 Weeks Volatility :70.78%
Upside
10.07%

Clearpoint Neuro Returns

Period	Clearpoint Neuro Inc	Sector (Health Care)	Index (Russel 2000)
3 Months	41.36%	-9.0%	0.0%
6 Months	176.5%	-4.6%	0.0%
1 Year	126.3%	3.0%	0.0%
3 Years	30.66%	0.0%	-21.1%

Clearpoint Neuro Key Statistics

in dollars & INR

Previous Close	$14.63
Open	$14.76
Today's High	$15.7495
Today's Low	$14.7101
Market Capitalization	$433.2M
Today's Volume	$123.9K
52 Week High	$17.4699
52 Week Low	$5.105
Revenue TTM	$30.4M
EBITDA	$-17.9M
Earnings Per Share (EPS)	$-0.69
Profit Margin	-59.64%
Quarterly Earnings Growth YOY	0.0%
Return On Equity TTM	-68.36%

How to invest in Clearpoint Neuro from India?

It is very easy for Indian residents to invest directly in Clearpoint Neuro from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Clearpoint Neuro stock in both Indian Rupees (INR) and US Dollars (USD). Search for Clearpoint Neuro or CLPT on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Clearpoint Neuro or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Clearpoint Neuro shares which would translate to 0.054 fractional shares of Clearpoint Neuro as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Clearpoint Neuro, in just a few clicks!

Returns in Clearpoint Neuro for Indian investors in Rupees

Investment Value

₹1,00,000

Clearpoint Neuro investment value today

Current value as on today

₹2,28,607

Returns

₹1,28,607

(+128.61%)

Returns from Clearpoint Neuro Stock

₹1,26,369 (+126.37%)

Dollar Returns

₹2,239 (+2.24%)

Indian investors sentiment towards Clearpoint Neuro

Period: Sep 26, 2024 to Dec 25, 2024. Change in 30 Days versus previous period

Search volume for Clearpoint Neuro on INDmoney from India has grown in the last 30 days as on Dec 26, 2024. 0% more investors are searching Clearpoint Neuro in the last 30 days versus the previous period.

Global Institutional Holdings in Clearpoint Neuro

Vanguard Group Inc
4.51%
Essex Investment Management Company, LLC
1.68%
Taylor Frigon Capital Management LLC
1.36%
BlackRock Inc
1.33%
Brown Advisory Holdings Inc
1.21%
CM Management, LLC
1.09%

Analyst Recommendation on Clearpoint Neuro

Buy

88%Buy

11%Hold

0%Sell

Based on 9 Wall street analysts offering stock ratings for Clearpoint Neuro(by analysts ranked 0 to 5 stars)

Based on 9 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast on Clearpoint Neuro

What analysts predicted

Upside of 8.21%

Current:

$15.71

Target:

$17.00

Insights on Clearpoint Neuro

Price Movement
In the last 1 month, CLPT stock has moved up by 31.3%
Increasing Revenue
Revenue is up for the last 5 quarters, 5.76M → 8.12M (in $), with an average increase of 8.1% per quarter
Decreasing Net Profit
Netprofit is down for the last 3 quarters, -4.14M → -4.97M (in $), with an average decrease of 9.6% per quarter
CLPT vs BSX (3 yr)
In the last 3 years, Boston Scientific Corp. has given 113.2% return, outperforming this stock by 79.7%

Clearpoint Neuro Financials in INR & Dollars

	FY18	Y/Y Change
Revenue	$7.4M	↓ 0.36%
Net Income	$-6.2M	↓ 14.01%
Net Profit Margin	-83.82%	↑ 13.3%

	FY19	Y/Y Change
Revenue	$11.2M	↑ 52.54%
Net Income	$-6.5M	↑ 5.53%
Net Profit Margin	-57.98%	↑ 25.84%

	FY20	Y/Y Change
Revenue	$12.8M	↑ 14.37%
Net Income	$-9.1M	↑ 40.04%
Net Profit Margin	-71.0%	↓ 13.02%

	FY21	Y/Y Change
Revenue	$16.3M	↑ 27.05%
Net Income	$-15.3M	↑ 68.2%
Net Profit Margin	-93.99%	↓ 22.99%

	FY22	Y/Y Change
Revenue	$20.6M	↑ 26.09%
Net Income	$-16.5M	↑ 7.95%
Net Profit Margin	-80.47%	↑ 13.52%

	FY23	Y/Y Change
Revenue	$24.0M	↑ 16.56%
Net Income	$-22.1M	↑ 33.57%
Net Profit Margin	-92.21%	↓ 11.74%

	Q2 FY23	Q/Q Change
Revenue	$6.0M	↑ 9.52%
Net Income	$-7.1M	↑ 30.79%
Net Profit Margin	-118.52%	↓ 19.27%

	Q3 FY23	Q/Q Change
Revenue	$5.8M	↓ 3.16%
Net Income	$-4.8M	↓ 31.81%
Net Profit Margin	-83.46%	↑ 35.06%

	Q4 FY23	Q/Q Change
Revenue	$6.8M	↑ 18.19%
Net Income	$-4.6M	↓ 3.95%
Net Profit Margin	-67.83%	↑ 15.63%

	Q1 FY24	Q/Q Change
Revenue	$7.6M	↑ 12.17%
Net Income	$-4.1M	↓ 10.24%
Net Profit Margin	-54.27%	↑ 13.56%

	Q2 FY24	Q/Q Change
Revenue	$7.9M	↑ 2.87%
Net Income	$-4.4M	↑ 6.32%
Net Profit Margin	-56.1%	↓ 1.83%

	Q3 FY24	Q/Q Change
Revenue	$8.1M	↑ 3.36%
Net Income	$-5.0M	↑ 12.84%
Net Profit Margin	-61.24%	↓ 5.14%

	FY18	Y/Y Change
Profit	$4.9M	↑ 9.81%

	FY19	Y/Y Change
Profit	$7.4M	↑ 50.08%

	FY20	Y/Y Change
Profit	$9.1M	↑ 23.51%

	FY21	Y/Y Change
Profit	$11.3M	↑ 23.8%

	FY22	Y/Y Change
Profit	$13.5M	↑ 19.84%

	FY23	Y/Y Change
Profit	$13.6M	↑ 0.61%

	Q2 FY23	Q/Q Change
Profit	$3.1M	↓ 2.37%

	Q3 FY23	Q/Q Change
Profit	$3.3M	↑ 4.7%

	Q4 FY23	Q/Q Change
Profit	$4.0M	↑ 22.61%

	Q1 FY24	Q/Q Change
Profit	$4.5M	↑ 12.76%

	Q2 FY24	Q/Q Change
Profit	$5.0M	↑ 10.23%

	Q3 FY24	Q/Q Change
Profit	$4.8M	↓ 2.83%

	FY18	Y/Y Change
Operating Cash Flow	$-4.6M	↓ 22.73%
Investing Cash Flow	$-63.5K	↑ 137.33%
Financing Cash Flow	$-1.5M	↓ 112.46%

	FY19	Y/Y Change
Operating Cash Flow	$-2.8M	↓ 38.46%
Investing Cash Flow	$-160.0K	↑ 152.01%
Financing Cash Flow	$5.6M	↓ 474.97%

	FY20	Y/Y Change
Operating Cash Flow	$-7.8M	↑ 174.01%
Investing Cash Flow	$-482.0K	↑ 201.25%
Financing Cash Flow	$22.7M	↑ 304.92%

	FY21	Y/Y Change
Operating Cash Flow	$-12.7M	↑ 62.62%
Investing Cash Flow	$-168.0K	↓ 65.15%
Financing Cash Flow	$46.9M	↑ 106.56%

	FY22	Y/Y Change
Operating Cash Flow	$-16.2M	↑ 27.33%
Investing Cash Flow	$-10.7M	↑ 6290.48%
Financing Cash Flow	$409.0K	↓ 99.13%

	Q2 FY23	Q/Q Change
Operating Cash Flow	$-5.1M	↓ 10.65%
Investing Cash Flow	$9.5M	↓ 6991.3%
Financing Cash Flow	$237.0K	↓ 4840.0%

Clearpoint Neuro Technicals Summary

Sell

Neutral

Buy

Clearpoint Neuro is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Clearpoint Neuro Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Clearpoint Neuro Inc	31.31%	176.5%	126.3%	30.66%	-14.92%
Stryker Corporation	-4.86%	8.88%	24.0%	37.11%	77.64%
Boston Scientific Corp.	0.95%	18.27%	62.57%	111.2%	102.42%
Edwards Lifesciences Corp.	5.35%	-19.24%	-1.09%	-42.27%	-2.7%
Abbott Laboratories	-2.71%	9.66%	4.53%	-18.87%	32.21%
Medtronic Plc	-4.83%	2.79%	-1.07%	-21.92%	-27.8%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Clearpoint Neuro Inc	NA	NA	NA	-0.67	-0.68	-0.28	NA	1.05
Stryker Corporation	39.7	39.7	2.56	12.06	0.19	0.07	0.01	52.86
Boston Scientific Corp.	75.26	75.26	1.65	2.46	0.09	0.05	NA	14.05
Edwards Lifesciences Corp.	29.1	29.1	6.92	2.55	0.19	0.11	NA	16.18
Abbott Laboratories	34.88	34.88	2.22	4.68	0.15	0.06	0.02	22.94
Medtronic Plc	24.94	24.94	1.49	5.2	0.08	0.04	0.03	38.29

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Clearpoint Neuro Inc	Buy	$433.2M	-14.92%	NA	-59.64%
Stryker Corporation	Buy	$141.3B	77.64%	39.7	16.34%
Boston Scientific Corp.	Buy	$134.2B	102.42%	75.26	11.26%
Edwards Lifesciences Corp.	Buy	$44.5B	-2.7%	29.1	65.86%
Abbott Laboratories	Buy	$199.0B	32.21%	34.88	13.99%
Medtronic Plc	Buy	$104.6B	-27.8%	24.94	12.06%

About Clearpoint Neuro

we are a medical device company that develops and commercializes innovative platforms for performing minimally invasive surgical procedures in the brain and heart under direct, intra-procedural magnetic resonance imaging, or mri, guidance. since our inception in 1998, we have focused on research and product development in the field of interventional mri. from 1998 to 2002, we deployed significant resources to fund our efforts to develop the foundational capabilities for enabling mri-guided interventions and to build an intellectual property position. in 2003, our focus shifted to identifying and building out commercial applications for the technologies we developed in prior years. we have two product platforms. our clearpoint® system, which is in commercial use in the united states, is used to perform minimally invasive surgical procedures in the brain. our cleartrace system, which is still in development, will be used to perform minimally invasive surgical procedures in the heart. bot

Organization	Clearpoint Neuro
Employees	107
CEO	Mr. Joseph Michael Burnett
Industry	Health Technology

Management People of Clearpoint Neuro

Name	Title
Mr. Joseph Michael Burnett	President, CEO & Director
Mr. Danilo D'Alessandro	Chief Financial Officer
Mr. Jeremy Stigall	Chief Business Officer
Mr. Mazin Sabra	Chief Operating Officer
Ms. Ellisa Cholapranee J.D.	General Counsel & Secretary
Ms. Jacqueline Keller	Vice President of Marketing

Important FAQs about investing in Clearpoint Neuro from India :

What is Clearpoint Neuro share price today?

Clearpoint Neuro share price today stands at $15.71, Open: $14.76 ; Previous Close: $14.63 ; High: $15.75 ; Low: $14.71 ; 52 Week High: $17.47 ; 52 Week Low: $5.11. The stock opens at $14.76, after a previous close of $14.63. The stock reached a daily high of $15.75 and a low of $14.71, with a 52-week high of $17.47 and a 52-week low of $5.11.

Can Indians buy Clearpoint Neuro shares?

Yes, Indians can invest in the Clearpoint Neuro (CLPT) from India.

With INDmoney, you can buy Clearpoint Neuro at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Clearpoint Neuro at zero transaction cost.

How can I buy Clearpoint Neuro shares from India?

It is very easy to buy Clearpoint Neuro from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Clearpoint Neuro be purchased?

Yes, you can buy fractional shares of Clearpoint Neuro with INDmoney app.

What are the documents required to start investing in Clearpoint Neuro stocks?

To start investing in Clearpoint Neuro, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.